(STLA) Stellantis - Overview
Stock: Automobiles, Commercial Vehicles, Engines, Transmissions, Mobility
| Risk 5d forecast | |
|---|---|
| Volatility | 43.0% |
| Relative Tail Risk | -4.21% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.59 |
| Alpha | -57.21 |
| Character TTM | |
|---|---|
| Beta | 1.624 |
| Beta Downside | 1.482 |
| Drawdowns 3y | |
|---|---|
| Max DD | 71.20% |
| CAGR/Max DD | -0.24 |
Description: STLA Stellantis February 11, 2026
Stellantis N.V. (NYSE: STLA) is a global automotive conglomerate that designs, engineers, manufactures, distributes, and sells a broad portfolio of passenger cars, light commercial vehicles, powertrains, and mobility services under 14 brands-including Jeep, Peugeot, Fiat, and Maserati-while also offering financing, leasing, and contract manufacturing solutions. Headquartered in Hoofddorp, the Netherlands, the group operates across all major markets and leverages shared platforms to achieve economies of scale.
Key recent metrics (Q4 2025): revenue of €84 billion (+5 % YoY), adjusted EBIT margin of 8.2 % (down 0.5 pp from the prior quarter) and an EV-penetration rate of 28 % of total vehicle deliveries, driven by strong demand for the Jeep Recon and Peugeot e-208. The company’s net debt stands at €20 billion, a 12 % reduction year-over-year, reflecting disciplined cost-control and a €1.5 billion share-repurchase program. Sector-wide, global passenger-vehicle sales are projected to grow 2-3 % in 2026, while tightening CO₂-emission standards in the EU and China are accelerating the shift toward electric drivetrains-both factors that directly affect Stellantis’s product roadmap and capital allocation.
For a deeper, data-driven view of how these dynamics translate into valuation risk and upside, consider exploring the detailed analyst framework on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 6.63b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.07 > 0.02 and ΔFCF/TA -14.34 > 1.0 |
| NWC/Revenue: 1.69% < 20% (prev 6.18%; Δ -4.50% < -1%) |
| CFO/TA 0.02 > 3% & CFO 4.06b > Net Income 6.63b |
| Net Debt (10.14b) to EBITDA (20.36b): 0.50 < 3 |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.88b) vs 12m ago -7.05% < -2% |
| Gross Margin: 12.99% > 18% (prev 0.20%; Δ 1279 % > 0.5%) |
| Asset Turnover: 135.9% > 50% (prev 140.7%; Δ -4.77% > 0%) |
| Interest Coverage Ratio: 4.44 > 6 (EBITDA TTM 20.36b / Interest Expense TTM 2.14b) |
Altman Z'' 2.26
| A: 0.02 (Total Current Assets 80.52b - Total Current Liabilities 75.91b) / Total Assets 200.68b |
| B: 0.36 (Retained Earnings 73.22b / Total Assets 200.68b) |
| C: 0.05 (EBIT TTM 9.52b / Avg Total Assets 201.41b) |
| D: 0.58 (Book Value of Equity 73.40b / Total Liabilities 127.16b) |
| Altman-Z'' Score: 2.26 = BBB |
Beneish M -2.37
| DSRI: 1.18 (Receivables 20.82b/18.26b, Revenue 273.70b/284.32b) |
| GMI: 1.55 (GM 12.99% / 20.13%) |
| AQI: 1.04 (AQ_t 0.38 / AQ_t-1 0.36) |
| SGI: 0.96 (Revenue 273.70b / 284.32b) |
| TATA: 0.01 (NI 6.63b - CFO 4.06b) / TA 200.68b) |
| Beneish M-Score: -2.37 (Cap -4..+1) = BBB |
What is the price of STLA shares?
Over the past week, the price has changed by +6.46%, over one month by -23.27%, over three months by -27.02% and over the past year by -37.64%.
Is STLA a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the STLA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 11.2 | 44% |
| Analysts Target Price | 11.2 | 44% |
| ValueRay Target Price | 8 | 3.6% |
STLA Fundamental Data Overview February 11, 2026
P/E Forward = 3.9635
P/S = 0.1445
P/B = 0.2442
P/EG = 0.3927
Revenue TTM = 273.70b EUR
EBIT TTM = 9.52b EUR
EBITDA TTM = 20.36b EUR
Long Term Debt = 25.95b EUR (from longTermDebt, last quarter)
Short Term Debt = 13.29b EUR (from shortTermDebt, last quarter)
Debt = 40.80b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.14b EUR (from netDebt column, last quarter)
Enterprise Value = 25.90b EUR (17.77b + Debt 40.80b - CCE 32.67b)
Interest Coverage Ratio = 4.44 (Ebit TTM 9.52b / Interest Expense TTM 2.14b)
EV/FCF = -1.83x (Enterprise Value 25.90b / FCF TTM -14.12b)
FCF Yield = -54.53% (FCF TTM -14.12b / Enterprise Value 25.90b)
FCF Margin = -5.16% (FCF TTM -14.12b / Revenue TTM 273.70b)
Net Margin = 2.42% (Net Income TTM 6.63b / Revenue TTM 273.70b)
Gross Margin = 12.99% ((Revenue TTM 273.70b - Cost of Revenue TTM 238.15b) / Revenue TTM)
Gross Margin QoQ = 8.45% (prev 7.92%)
Tobins Q-Ratio = 0.13 (Enterprise Value 25.90b / Total Assets 200.68b)
Interest Expense / Debt = 1.68% (Interest Expense 684.4m / Debt 40.80b)
Taxrate = 21.0% (US default 21%)
NOPAT = 7.52b (EBIT 9.52b * (1 - 21.00%))
Current Ratio = 1.06 (Total Current Assets 80.52b / Total Current Liabilities 75.91b)
Debt / Equity = 0.56 (Debt 40.80b / totalStockholderEquity, last quarter 73.12b)
Debt / EBITDA = 0.50 (Net Debt 10.14b / EBITDA 20.36b)
Debt / FCF = -0.72 (negative FCF - burning cash) (Net Debt 10.14b / FCF TTM -14.12b)
Total Stockholder Equity = 62.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.29% (Net Income 6.63b / Total Assets 200.68b)
RoE = 10.63% (Net Income TTM 6.63b / Total Stockholder Equity 62.33b)
RoCE = 10.79% (EBIT 9.52b / Capital Employed (Equity 62.33b + L.T.Debt 25.95b))
RoIC = 6.65% (NOPAT 7.52b / Invested Capital 113.15b)
WACC = 4.53% (E(17.77b)/V(58.57b) * Re(11.90%) + D(40.80b)/V(58.57b) * Rd(1.68%) * (1-Tc(0.21)))
Discount Rate = 11.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.59%
Fair Price DCF = unknown (Cash Flow -14.12b)
EPS Correlation: -46.57 | EPS CAGR: -46.67% | SUE: -0.06 | # QB: 0
Revenue Correlation: 21.43 | Revenue CAGR: 0.64% | SUE: 0.91 | # QB: 1
EPS next Year (2026-12-31): EPS=1.74 | Chg30d=-0.254 | Revisions Net=+0 | Growth EPS=+127.0% | Growth Revenue=+5.6%